Anxiety rating scales in Parkinson's disease: A validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale
Identifieur interne : 000163 ( Istex/Corpus ); précédent : 000162; suivant : 000164Anxiety rating scales in Parkinson's disease: A validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale
Auteurs : Albert F. G. Leentjens ; Kathy Dujardin ; Laura Marsh ; Irene H. Richard ; Sergio E. Starkstein ; Pablo Martinez-MartinSource :
- Movement Disorders [ 0885-3185 ] ; 2011-02-15.
English descriptors
- KwdEn :
- Anxiety, Anxiety diagnoses, Anxiety disorder, Anxiety disorders, Anxiety disturbances, Anxiety factor, Anxiety hars, Anxiety rating scales, Anxiety scale, Anxiety scales, Anxiety section, Anxiety subscale, Anxiety symptoms, Anxiety syndromes, Beck anxiety inventory, Ceiling effects, Clin, Clin epidemiol, Clinical practice, Clinimetric, Clinimetric properties, Content validity, Convergent, Convergent validity, Depression rating scales, Depression scale, Depression subscale, Depressive, Depressive symptoms, Diagnostic criteria, Diagnostic tests, Different anxiety disorders, Different levels, Different scales, Disord, Disorder, Factor analysis, Factor solution, Factorial structure, Fremantle hospital, Generalized anxiety, Good acceptability, Groups validity, Hads, Hads subscales, Hamilton anxiety rating scale, Hars, Health technol, Higher scores, Highest scores, Hospital anxiety, Information table, Information tables, Internal consistency, Intraclass correlation, Item homogeneity, Johns hopkins university school, Laura marsh, Lille university hospital, Maastricht university, Major depressive disorder, Major depressive episode, Median scores, Mini, Movement disorders, Neuropsychiatr clin neurosci, Neuropsychiatric inventory, Nonepisodic anxiety disorders, Online version, Panic attacks, Panic disorder, Phobia, Principal component analysis, Psychiatric disease, Psychometric properties, Qual life, Rating, Rating scales, Recent study, Reliability, Rochester school, Sample size, Scale score, Score distributions, Scree plot, Social phobia, Standard error, Symptom, Symptom severity, Task forces, Total hads, Total hads score, Total score, Variance, Western australia, Youden index.
- Teeft :
- Anxiety, Anxiety diagnoses, Anxiety disorder, Anxiety disorders, Anxiety disturbances, Anxiety factor, Anxiety hars, Anxiety rating scales, Anxiety scale, Anxiety scales, Anxiety section, Anxiety subscale, Anxiety symptoms, Anxiety syndromes, Beck anxiety inventory, Ceiling effects, Clin, Clin epidemiol, Clinical practice, Clinimetric, Clinimetric properties, Content validity, Convergent, Convergent validity, Depression rating scales, Depression scale, Depression subscale, Depressive, Depressive symptoms, Diagnostic criteria, Diagnostic tests, Different anxiety disorders, Different levels, Different scales, Disord, Disorder, Factor analysis, Factor solution, Factorial structure, Fremantle hospital, Generalized anxiety, Good acceptability, Groups validity, Hads, Hads subscales, Hamilton anxiety rating scale, Hars, Health technol, Higher scores, Highest scores, Hospital anxiety, Information table, Information tables, Internal consistency, Intraclass correlation, Item homogeneity, Johns hopkins university school, Laura marsh, Lille university hospital, Maastricht university, Major depressive disorder, Major depressive episode, Median scores, Mini, Movement disorders, Neuropsychiatr clin neurosci, Neuropsychiatric inventory, Nonepisodic anxiety disorders, Online version, Panic attacks, Panic disorder, Phobia, Principal component analysis, Psychiatric disease, Psychometric properties, Qual life, Rating, Rating scales, Recent study, Reliability, Rochester school, Sample size, Scale score, Score distributions, Scree plot, Social phobia, Standard error, Symptom, Symptom severity, Task forces, Total hads, Total hads score, Total score, Variance, Western australia, Youden index.
Abstract
Anxiety is a prevalent and disabling condition in Parkinson's disease (PD). The lack of anxiety rating scales validated for this population hampers research into anxiety in PD. The aim of this study is to assess the clinimetric properties of the Hamilton anxiety rating scale (HARS), the Beck anxiety inventory (BAI), and the hospital anxiety and depression scale (HADS) in PD patients.
Url:
DOI: 10.1002/mds.23184
Links to Exploration step
ISTEX:08277AF9837056E4B0F595949AA5A9C168BB6F93Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Anxiety rating scales in Parkinson's disease: A validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale</title><author><name sortKey="Leentjens, Albert F G" sort="Leentjens, Albert F G" uniqKey="Leentjens A" first="Albert F. G." last="Leentjens">Albert F. G. Leentjens</name><affiliation><mods:affiliation>Department of Psychiatry, Maastricht University Medical Center, Maastricht, The Netherlands</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: a.leentjens@np.unimaas.nl</mods:affiliation></affiliation><affiliation><mods:affiliation>Correspondence address: Department of Psychiatry, Maastricht University Medical Center, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Dujardin, Kathy" sort="Dujardin, Kathy" uniqKey="Dujardin K" first="Kathy" last="Dujardin">Kathy Dujardin</name><affiliation><mods:affiliation>Neurology and Movement Disorders Unit, Lille University Hospital, Lille, France</mods:affiliation></affiliation></author><author><name sortKey="Marsh, Laura" sort="Marsh, Laura" uniqKey="Marsh L" first="Laura" last="Marsh">Laura Marsh</name><affiliation><mods:affiliation>Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA</mods:affiliation></affiliation><affiliation><mods:affiliation>Current Address: Laura Marsh Mental Health Care Line, Michael E. DeBakey Veterans Administration Medical Center and Menninger Department of Psychiatry, Baylor College of Medicine, Houston, Texas, USA</mods:affiliation></affiliation></author><author><name sortKey="Richard, Irene H" sort="Richard, Irene H" uniqKey="Richard I" first="Irene H." last="Richard">Irene H. Richard</name><affiliation><mods:affiliation>Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Psychiatry, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA</mods:affiliation></affiliation></author><author><name sortKey="Starkstein, Sergio E" sort="Starkstein, Sergio E" uniqKey="Starkstein S" first="Sergio E." last="Starkstein">Sergio E. Starkstein</name><affiliation><mods:affiliation>School of Psychiatry, University of Western Australia and Fremantle Hospital, Fremantle, Western Australia, Australia</mods:affiliation></affiliation></author><author><name sortKey="Martinez Artin, Pablo" sort="Martinez Artin, Pablo" uniqKey="Martinez Artin P" first="Pablo" last="Martinez-Martin">Pablo Martinez-Martin</name><affiliation><mods:affiliation>Area of Applied Epidemiology and CIBERNED, National Centre for Epidemiology, Carlos III Institute of Health, Madrid, Spain</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:08277AF9837056E4B0F595949AA5A9C168BB6F93</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1002/mds.23184</idno><idno type="url">https://api.istex.fr/document/08277AF9837056E4B0F595949AA5A9C168BB6F93/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000163</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000163</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Anxiety rating scales in Parkinson's disease: A validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale<ref type="note" target="#fn1"></ref></title><author><name sortKey="Leentjens, Albert F G" sort="Leentjens, Albert F G" uniqKey="Leentjens A" first="Albert F. G." last="Leentjens">Albert F. G. Leentjens</name><affiliation><mods:affiliation>Department of Psychiatry, Maastricht University Medical Center, Maastricht, The Netherlands</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: a.leentjens@np.unimaas.nl</mods:affiliation></affiliation><affiliation><mods:affiliation>Correspondence address: Department of Psychiatry, Maastricht University Medical Center, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Dujardin, Kathy" sort="Dujardin, Kathy" uniqKey="Dujardin K" first="Kathy" last="Dujardin">Kathy Dujardin</name><affiliation><mods:affiliation>Neurology and Movement Disorders Unit, Lille University Hospital, Lille, France</mods:affiliation></affiliation></author><author><name sortKey="Marsh, Laura" sort="Marsh, Laura" uniqKey="Marsh L" first="Laura" last="Marsh">Laura Marsh</name><affiliation><mods:affiliation>Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA</mods:affiliation></affiliation><affiliation><mods:affiliation>Current Address: Laura Marsh Mental Health Care Line, Michael E. DeBakey Veterans Administration Medical Center and Menninger Department of Psychiatry, Baylor College of Medicine, Houston, Texas, USA</mods:affiliation></affiliation></author><author><name sortKey="Richard, Irene H" sort="Richard, Irene H" uniqKey="Richard I" first="Irene H." last="Richard">Irene H. Richard</name><affiliation><mods:affiliation>Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Psychiatry, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA</mods:affiliation></affiliation></author><author><name sortKey="Starkstein, Sergio E" sort="Starkstein, Sergio E" uniqKey="Starkstein S" first="Sergio E." last="Starkstein">Sergio E. Starkstein</name><affiliation><mods:affiliation>School of Psychiatry, University of Western Australia and Fremantle Hospital, Fremantle, Western Australia, Australia</mods:affiliation></affiliation></author><author><name sortKey="Martinez Artin, Pablo" sort="Martinez Artin, Pablo" uniqKey="Martinez Artin P" first="Pablo" last="Martinez-Martin">Pablo Martinez-Martin</name><affiliation><mods:affiliation>Area of Applied Epidemiology and CIBERNED, National Centre for Epidemiology, Carlos III Institute of Health, Madrid, Spain</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Movement Disorders</title><title level="j" type="alt">MOVEMENT DISORDERS</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><biblScope unit="vol">26</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="407">407</biblScope><biblScope unit="page" to="415">415</biblScope><biblScope unit="page-count">9</biblScope><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2011-02-15">2011-02-15</date></imprint><idno type="ISSN">0885-3185</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anxiety</term><term>Anxiety diagnoses</term><term>Anxiety disorder</term><term>Anxiety disorders</term><term>Anxiety disturbances</term><term>Anxiety factor</term><term>Anxiety hars</term><term>Anxiety rating scales</term><term>Anxiety scale</term><term>Anxiety scales</term><term>Anxiety section</term><term>Anxiety subscale</term><term>Anxiety symptoms</term><term>Anxiety syndromes</term><term>Beck anxiety inventory</term><term>Ceiling effects</term><term>Clin</term><term>Clin epidemiol</term><term>Clinical practice</term><term>Clinimetric</term><term>Clinimetric properties</term><term>Content validity</term><term>Convergent</term><term>Convergent validity</term><term>Depression rating scales</term><term>Depression scale</term><term>Depression subscale</term><term>Depressive</term><term>Depressive symptoms</term><term>Diagnostic criteria</term><term>Diagnostic tests</term><term>Different anxiety disorders</term><term>Different levels</term><term>Different scales</term><term>Disord</term><term>Disorder</term><term>Factor analysis</term><term>Factor solution</term><term>Factorial structure</term><term>Fremantle hospital</term><term>Generalized anxiety</term><term>Good acceptability</term><term>Groups validity</term><term>Hads</term><term>Hads subscales</term><term>Hamilton anxiety rating scale</term><term>Hars</term><term>Health technol</term><term>Higher scores</term><term>Highest scores</term><term>Hospital anxiety</term><term>Information table</term><term>Information tables</term><term>Internal consistency</term><term>Intraclass correlation</term><term>Item homogeneity</term><term>Johns hopkins university school</term><term>Laura marsh</term><term>Lille university hospital</term><term>Maastricht university</term><term>Major depressive disorder</term><term>Major depressive episode</term><term>Median scores</term><term>Mini</term><term>Movement disorders</term><term>Neuropsychiatr clin neurosci</term><term>Neuropsychiatric inventory</term><term>Nonepisodic anxiety disorders</term><term>Online version</term><term>Panic attacks</term><term>Panic disorder</term><term>Phobia</term><term>Principal component analysis</term><term>Psychiatric disease</term><term>Psychometric properties</term><term>Qual life</term><term>Rating</term><term>Rating scales</term><term>Recent study</term><term>Reliability</term><term>Rochester school</term><term>Sample size</term><term>Scale score</term><term>Score distributions</term><term>Scree plot</term><term>Social phobia</term><term>Standard error</term><term>Symptom</term><term>Symptom severity</term><term>Task forces</term><term>Total hads</term><term>Total hads score</term><term>Total score</term><term>Variance</term><term>Western australia</term><term>Youden index</term></keywords><keywords scheme="Teeft" xml:lang="en"><term>Anxiety</term><term>Anxiety diagnoses</term><term>Anxiety disorder</term><term>Anxiety disorders</term><term>Anxiety disturbances</term><term>Anxiety factor</term><term>Anxiety hars</term><term>Anxiety rating scales</term><term>Anxiety scale</term><term>Anxiety scales</term><term>Anxiety section</term><term>Anxiety subscale</term><term>Anxiety symptoms</term><term>Anxiety syndromes</term><term>Beck anxiety inventory</term><term>Ceiling effects</term><term>Clin</term><term>Clin epidemiol</term><term>Clinical practice</term><term>Clinimetric</term><term>Clinimetric properties</term><term>Content validity</term><term>Convergent</term><term>Convergent validity</term><term>Depression rating scales</term><term>Depression scale</term><term>Depression subscale</term><term>Depressive</term><term>Depressive symptoms</term><term>Diagnostic criteria</term><term>Diagnostic tests</term><term>Different anxiety disorders</term><term>Different levels</term><term>Different scales</term><term>Disord</term><term>Disorder</term><term>Factor analysis</term><term>Factor solution</term><term>Factorial structure</term><term>Fremantle hospital</term><term>Generalized anxiety</term><term>Good acceptability</term><term>Groups validity</term><term>Hads</term><term>Hads subscales</term><term>Hamilton anxiety rating scale</term><term>Hars</term><term>Health technol</term><term>Higher scores</term><term>Highest scores</term><term>Hospital anxiety</term><term>Information table</term><term>Information tables</term><term>Internal consistency</term><term>Intraclass correlation</term><term>Item homogeneity</term><term>Johns hopkins university school</term><term>Laura marsh</term><term>Lille university hospital</term><term>Maastricht university</term><term>Major depressive disorder</term><term>Major depressive episode</term><term>Median scores</term><term>Mini</term><term>Movement disorders</term><term>Neuropsychiatr clin neurosci</term><term>Neuropsychiatric inventory</term><term>Nonepisodic anxiety disorders</term><term>Online version</term><term>Panic attacks</term><term>Panic disorder</term><term>Phobia</term><term>Principal component analysis</term><term>Psychiatric disease</term><term>Psychometric properties</term><term>Qual life</term><term>Rating</term><term>Rating scales</term><term>Recent study</term><term>Reliability</term><term>Rochester school</term><term>Sample size</term><term>Scale score</term><term>Score distributions</term><term>Scree plot</term><term>Social phobia</term><term>Standard error</term><term>Symptom</term><term>Symptom severity</term><term>Task forces</term><term>Total hads</term><term>Total hads score</term><term>Total score</term><term>Variance</term><term>Western australia</term><term>Youden index</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract">Anxiety is a prevalent and disabling condition in Parkinson's disease (PD). The lack of anxiety rating scales validated for this population hampers research into anxiety in PD. The aim of this study is to assess the clinimetric properties of the Hamilton anxiety rating scale (HARS), the Beck anxiety inventory (BAI), and the hospital anxiety and depression scale (HADS) in PD patients.</div></front></TEI><istex><corpusName>wiley</corpusName><keywords><teeft><json:string>hads</json:string><json:string>hars</json:string><json:string>anxiety disorder</json:string><json:string>anxiety disorders</json:string><json:string>mini</json:string><json:string>anxiety symptoms</json:string><json:string>anxiety scales</json:string><json:string>depressive</json:string><json:string>anxiety rating scales</json:string><json:string>rating scales</json:string><json:string>phobia</json:string><json:string>panic disorder</json:string><json:string>clinimetric</json:string><json:string>clin</json:string><json:string>movement disorders</json:string><json:string>groups validity</json:string><json:string>variance</json:string><json:string>disord</json:string><json:string>convergent</json:string><json:string>hospital anxiety</json:string><json:string>clinimetric properties</json:string><json:string>reliability</json:string><json:string>total hads</json:string><json:string>depression scale</json:string><json:string>social phobia</json:string><json:string>anxiety scale</json:string><json:string>disorder</json:string><json:string>clinical practice</json:string><json:string>convergent validity</json:string><json:string>different levels</json:string><json:string>diagnostic criteria</json:string><json:string>ceiling effects</json:string><json:string>score distributions</json:string><json:string>scree plot</json:string><json:string>symptom</json:string><json:string>anxiety factor</json:string><json:string>different scales</json:string><json:string>hamilton anxiety rating scale</json:string><json:string>anxiety diagnoses</json:string><json:string>rochester school</json:string><json:string>johns hopkins university school</json:string><json:string>psychometric properties</json:string><json:string>neuropsychiatric inventory</json:string><json:string>factorial structure</json:string><json:string>youden index</json:string><json:string>factor solution</json:string><json:string>maastricht university</json:string><json:string>qual life</json:string><json:string>panic attacks</json:string><json:string>depression subscale</json:string><json:string>neuropsychiatr clin neurosci</json:string><json:string>nonepisodic anxiety disorders</json:string><json:string>information table</json:string><json:string>clin epidemiol</json:string><json:string>beck anxiety inventory</json:string><json:string>principal component analysis</json:string><json:string>different anxiety disorders</json:string><json:string>sample size</json:string><json:string>anxiety</json:string><json:string>standard error</json:string><json:string>health technol</json:string><json:string>factor analysis</json:string><json:string>intraclass correlation</json:string><json:string>diagnostic tests</json:string><json:string>item homogeneity</json:string><json:string>internal consistency</json:string><json:string>major depressive episode</json:string><json:string>good acceptability</json:string><json:string>highest scores</json:string><json:string>major depressive disorder</json:string><json:string>scale score</json:string><json:string>total hads score</json:string><json:string>content validity</json:string><json:string>anxiety hars</json:string><json:string>median scores</json:string><json:string>anxiety subscale</json:string><json:string>higher scores</json:string><json:string>hads subscales</json:string><json:string>total score</json:string><json:string>anxiety section</json:string><json:string>depressive symptoms</json:string><json:string>information tables</json:string><json:string>depression rating scales</json:string><json:string>anxiety disturbances</json:string><json:string>psychiatric disease</json:string><json:string>task forces</json:string><json:string>recent study</json:string><json:string>anxiety syndromes</json:string><json:string>generalized anxiety</json:string><json:string>online version</json:string><json:string>symptom severity</json:string><json:string>fremantle hospital</json:string><json:string>western australia</json:string><json:string>lille university hospital</json:string><json:string>laura marsh</json:string><json:string>rating</json:string></teeft></keywords><author><json:item><name>Albert F.G. Leentjens MD, PhD</name><affiliations><json:string>Department of Psychiatry, Maastricht University Medical Center, Maastricht, The Netherlands</json:string><json:string>E-mail: a.leentjens@np.unimaas.nl</json:string><json:string>Correspondence address: Department of Psychiatry, Maastricht University Medical Center, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands</json:string></affiliations></json:item><json:item><name>Kathy Dujardin PhD</name><affiliations><json:string>Neurology and Movement Disorders Unit, Lille University Hospital, Lille, France</json:string></affiliations></json:item><json:item><name>Laura Marsh MD</name><affiliations><json:string>Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA</json:string><json:string>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA</json:string><json:string>Current Address: Laura Marsh Mental Health Care Line, Michael E. DeBakey Veterans Administration Medical Center and Menninger Department of Psychiatry, Baylor College of Medicine, Houston, Texas, USA</json:string></affiliations></json:item><json:item><name>Irene H. Richard MD</name><affiliations><json:string>Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA</json:string><json:string>Department of Psychiatry, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA</json:string></affiliations></json:item><json:item><name>Sergio E. Starkstein MD</name><affiliations><json:string>School of Psychiatry, University of Western Australia and Fremantle Hospital, Fremantle, Western Australia, Australia</json:string></affiliations></json:item><json:item><name>Pablo Martinez‐Martin MD, PhD</name><affiliations><json:string>Area of Applied Epidemiology and CIBERNED, National Centre for Epidemiology, Carlos III Institute of Health, Madrid, Spain</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Parkinson's disease</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>anxiety</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>depression</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>clinimetrics</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>psychometrics</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>rating scales</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>validity</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>reliability</value></json:item></subject><articleId><json:string>MDS23184</json:string></articleId><arkIstex>ark:/67375/WNG-747J0S49-X</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>article</json:string></originalGenre><abstract>Anxiety is a prevalent and disabling condition in Parkinson's disease (PD). The lack of anxiety rating scales validated for this population hampers research into anxiety in PD. The aim of this study is to assess the clinimetric properties of the Hamilton anxiety rating scale (HARS), the Beck anxiety inventory (BAI), and the hospital anxiety and depression scale (HADS) in PD patients.</abstract><qualityIndicators><score>7.732</score><pdfWordCount>6017</pdfWordCount><pdfCharCount>39203</pdfCharCount><pdfVersion>1.3</pdfVersion><pdfPageCount>9</pdfPageCount><pdfPageSize>612 x 810 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractWordCount>61</abstractWordCount><abstractCharCount>386</abstractCharCount><keywordCount>8</keywordCount></qualityIndicators><title>Anxiety rating scales in Parkinson's disease: A validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale</title><pmid><json:string>21384425</json:string></pmid><genre><json:string>article</json:string></genre><host><title>Movement Disorders</title><language><json:string>unknown</json:string></language><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi><issn><json:string>0885-3185</json:string></issn><eissn><json:string>1531-8257</json:string></eissn><publisherId><json:string>MDS</json:string></publisherId><volume>26</volume><issue>3</issue><pages><first>407</first><last>415</last><total>9</total></pages><genre><json:string>journal</json:string></genre><subject><json:item><value>Research Article</value></json:item></subject></host><namedEntities><unitex><date><json:string>2011</json:string></date><geogName></geogName><orgName><json:string>DeBakey Veterans Administration Medical Center</json:string><json:string>University of Rochester School of Medicine</json:string><json:string>Institute of Health, Madrid, Spain</json:string><json:string>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA</json:string><json:string>Members of the UPDRS Committee</json:string><json:string>Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA</json:string><json:string>Fremantle Hospital, Fremantle</json:string><json:string>Medical Center, Maastricht</json:string><json:string>Johns Hopkins University</json:string><json:string>Department of Psychiatry, Maastricht University Medical Center</json:string><json:string>NINDS/NIMH Work Group on Depression and Parkinson's Disease</json:string><json:string>University of Western Australia and Fremantle Hospital, Fremantle, Western Australia, Australia</json:string><json:string>Department of Psychiatry, Maastricht University Medical Center, Maastricht, The Netherlands</json:string><json:string>Lille University Hospital, Lille, France</json:string><json:string>Department of Psychiatry, University of Rochester School of Medicine and Dentistry</json:string><json:string>Maastricht University</json:string><json:string>Scientific Advisory Committee of the Medical Outcomes Trust</json:string><json:string>Institute of Health, Madrid, Spain ABSTRACT</json:string><json:string>Menninger Department of Psychiatry, Baylor College of Medicine, Houston, Texas, USA</json:string><json:string>American Psychiatric Association</json:string><json:string>Longitudinal Parkinson's Disease Patient Study Group</json:string><json:string>National Centre for Epidemiology, Carlos</json:string><json:string>Department of Neurology, University of Rochester School of Medicine and Dentistry</json:string></orgName><orgName_funder></orgName_funder><orgName_provider></orgName_provider><persName><json:string>Laura Marsh</json:string><json:string>P.O. Box</json:string><json:string>Pablo Martinez-Martin</json:string><json:string>Estimates</json:string><json:string>Kathy Dujardin</json:string><json:string>Irene H. Richard</json:string><json:string>The</json:string><json:string>W. van der Elst</json:string><json:string>To</json:string><json:string>A.F.G. Leentjens</json:string><json:string>Sergio E. Starkstein</json:string></persName><placeName><json:string>Maastricht</json:string><json:string>Rochester</json:string><json:string>United States</json:string><json:string>NY</json:string><json:string>Australia</json:string><json:string>Europe</json:string><json:string>Baltimore</json:string><json:string>MD</json:string><json:string>Chicago</json:string><json:string>York</json:string><json:string>Netherlands</json:string></placeName><ref_url></ref_url><ref_bibl><json:string>Marinus et al.</json:string><json:string>Pontone et al.</json:string><json:string>Rodriguez-Blazquez et al.</json:string></ref_bibl><bibl></bibl></unitex></namedEntities><ark><json:string>ark:/67375/WNG-747J0S49-X</json:string></ark><categories><wos><json:string>1 - science</json:string><json:string>2 - clinical neurology</json:string></wos><scienceMetrix><json:string>1 - health sciences</json:string><json:string>2 - clinical medicine</json:string><json:string>3 - neurology & neurosurgery</json:string></scienceMetrix><scopus><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - Clinical Neurology</json:string><json:string>1 - Life Sciences</json:string><json:string>2 - Neuroscience</json:string><json:string>3 - Neurology</json:string></scopus></categories><publicationDate>2011</publicationDate><copyrightDate>2011</copyrightDate><doi><json:string>10.1002/mds.23184</json:string></doi><id>08277AF9837056E4B0F595949AA5A9C168BB6F93</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/document/08277AF9837056E4B0F595949AA5A9C168BB6F93/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/document/08277AF9837056E4B0F595949AA5A9C168BB6F93/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/08277AF9837056E4B0F595949AA5A9C168BB6F93/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Anxiety rating scales in Parkinson's disease: A validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale<ref type="note" target="#fn1"></ref></title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><licence>Copyright © 2011 Movement Disorder Society</licence></availability><date type="published" when="2011-02-15"></date></publicationStmt><notesStmt><note type="content-type" subtype="article" source="article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</note><note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="article"><analytic><title level="a" type="main" xml:lang="en">Anxiety rating scales in Parkinson's disease: A validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale<ref type="note" target="#fn1"></ref></title><title level="a" type="short" xml:lang="en">Validation of Anxiety Rating Scales in PD</title><author xml:id="author-0000" role="corresp"><persName><forename type="first">Albert F.G.</forename><surname>Leentjens</surname><roleName type="degree">MD, PhD</roleName></persName><email>a.leentjens@np.unimaas.nl</email><affiliation>Department of Psychiatry, Maastricht University Medical Center, Maastricht, The Netherlands<address><country key="NL"></country></address></affiliation><affiliation>Department of Psychiatry, Maastricht University Medical Center, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands</affiliation></author><author xml:id="author-0001"><persName><forename type="first">Kathy</forename><surname>Dujardin</surname><roleName type="degree">PhD</roleName></persName><affiliation>Neurology and Movement Disorders Unit, Lille University Hospital, Lille, France<address><country key="FR"></country></address></affiliation></author><author xml:id="author-0002"><persName><forename type="first">Laura</forename><surname>Marsh</surname><roleName type="degree">MD</roleName></persName><affiliation>Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA<address><country key="US"></country></address></affiliation><affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA<address><country key="US"></country></address></affiliation><affiliation>Current Address: Laura Marsh Mental Health Care Line, Michael E. DeBakey Veterans Administration Medical Center and Menninger Department of Psychiatry, Baylor College of Medicine, Houston, Texas, USA<address><country key="US"></country></address></affiliation></author><author xml:id="author-0003"><persName><forename type="first">Irene H.</forename><surname>Richard</surname><roleName type="degree">MD</roleName></persName><affiliation>Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA<address><country key="US"></country></address></affiliation><affiliation>Department of Psychiatry, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA<address><country key="US"></country></address></affiliation></author><author xml:id="author-0004"><persName><forename type="first">Sergio E.</forename><surname>Starkstein</surname><roleName type="degree">MD</roleName></persName><affiliation>School of Psychiatry, University of Western Australia and Fremantle Hospital, Fremantle, Western Australia, Australia<address><country key="AU"></country></address></affiliation></author><author xml:id="author-0005"><persName><forename type="first">Pablo</forename><surname>Martinez‐Martin</surname><roleName type="degree">MD, PhD</roleName></persName><affiliation>Area of Applied Epidemiology and CIBERNED, National Centre for Epidemiology, Carlos III Institute of Health, Madrid, Spain<address><country key="ES"></country></address></affiliation></author><idno type="istex">08277AF9837056E4B0F595949AA5A9C168BB6F93</idno><idno type="ark">ark:/67375/WNG-747J0S49-X</idno><idno type="DOI">10.1002/mds.23184</idno><idno type="unit">MDS23184</idno><idno type="toTypesetVersion">file:MDS.MDS23184.pdf</idno></analytic><monogr><title level="j" type="main">Movement Disorders</title><title level="j" type="alt">MOVEMENT DISORDERS</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="book-DOI">10.1002/(ISSN)1531-8257</idno><idno type="book-part-DOI">10.1002/mds.v26.3</idno><idno type="product">MDS</idno><imprint><biblScope unit="vol">26</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="407">407</biblScope><biblScope unit="page" to="415">415</biblScope><biblScope unit="page-count">9</biblScope><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2011-02-15"></date></imprint></monogr></biblStruct></sourceDesc></fileDesc><profileDesc><abstract xml:lang="en" style="main"><head>Abstract</head>
Background:
<p>Anxiety is a prevalent and disabling condition in Parkinson's disease (PD). The lack of anxiety rating scales validated for this population hampers research into anxiety in PD. The aim of this study is to assess the clinimetric properties of the Hamilton anxiety rating scale (HARS), the Beck anxiety inventory (BAI), and the hospital anxiety and depression scale (HADS) in PD patients.</p>
Design:
<p>Three hundred forty‐two PD patients underwent a standardized assessment including a structured interview for diagnostic and statistical manual diagnoses of anxiety disorders and completion of the HARS, BAI, and HADS. Inter‐rater reliability of the HARS was assessed in 60 patients; test‐retest reliability of the BAI and HADS in 213 and 217 patients, respectively.</p>
Results:
<p>Thirty‐four percent of patients suffered from an anxiety disorder, whereas an additional 11.4% had clinically significant anxiety symptoms in the absence of a diagnosis of anxiety disorder. Acceptability, score distribution, and known groups validity over different levels of anxiety were adequate. Inter‐rater reliability for the HARS and test‐retest reliability for the BAI and HADS were good. The HARS, but not the BAI and HADS, had a satisfactory inter‐item correlation, convergent validity and factorial structure. For all scales, the positive predictive value was poor, and the negative predictive value was moderate.</p>
Conclusions:
<p>Given the adequate known groups validity of all three rating scales, each of these scales is likely to be useful in clinical practice or research for evaluation of symptom severity. Limitations in the construct validity of the anxiety scales in this study raise questions regarding suitability for their use in PD. © 2011 Movement Disorder Society</p></abstract><textClass><keywords xml:lang="en"><term xml:id="kwd1">Parkinson's disease</term><term xml:id="kwd2">anxiety</term><term xml:id="kwd3">depression</term><term xml:id="kwd4">clinimetrics</term><term xml:id="kwd5">psychometrics</term><term xml:id="kwd6">rating scales</term><term xml:id="kwd7">validity</term><term xml:id="kwd8">reliability</term></keywords><keywords rend="articleCategory"><term>Research Article</term></keywords><keywords rend="tocHeading1"><term>Research Articles</term></keywords></textClass><langUsage><language ident="en"></language></langUsage></profileDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/document/08277AF9837056E4B0F595949AA5A9C168BB6F93/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="30"><doi origin="wiley" registered="yes">10.1002/mds.v26.3</doi><numberingGroup><numbering type="journalVolume" number="26">26</numbering><numbering type="journalIssue">3</numbering></numberingGroup><coverDate startDate="2011-02-15">15 February 2011</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="100" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.23184</doi><idGroup><id type="unit" value="MDS23184"></id></idGroup><countGroup><count type="pageTotal" number="9"></count></countGroup><titleGroup><title type="articleCategory">Research Article</title><title type="tocHeading1">Research Articles</title></titleGroup><copyright ownership="thirdParty">Copyright © 2011 Movement Disorder Society</copyright><eventGroup><event type="manuscriptReceived" date="2010-01-11"></event><event type="manuscriptRevised" date="2010-03-12"></event><event type="manuscriptAccepted" date="2010-03-23"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:3.0.1 mode:FullText" date="2012-01-12"></event><event type="publishedOnlineEarlyUnpaginated" date="2011-03-07"></event><event type="publishedOnlineFinalForm" date="2011-03-31"></event><event type="firstOnline" date="2011-03-07"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">407</numbering><numbering type="pageLast">415</numbering></numberingGroup><correspondenceTo>Department of Psychiatry, Maastricht University Medical Center, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS23184.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="0"></count><count type="tableTotal" number="7"></count><count type="referenceTotal" number="42"></count><count type="wordTotal" number="8355"></count></countGroup><titleGroup><title type="main" xml:lang="en">Anxiety rating scales in Parkinson's disease: A validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale<link href="#fn1"></link></title><title type="short" xml:lang="en">Validation of Anxiety Rating Scales in PD</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>Albert F.G.</givenNames><familyName>Leentjens</familyName><degrees>MD, PhD</degrees></personName><contactDetails><email>a.leentjens@np.unimaas.nl</email></contactDetails></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Kathy</givenNames><familyName>Dujardin</familyName><degrees>PhD</degrees></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af3 #af4" currentRef="#curr1"><personName><givenNames>Laura</givenNames><familyName>Marsh</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au4" creatorRole="author" affiliationRef="#af5 #af6"><personName><givenNames>Irene H.</givenNames><familyName>Richard</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au5" creatorRole="author" affiliationRef="#af7"><personName><givenNames>Sergio E.</givenNames><familyName>Starkstein</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au6" creatorRole="author" affiliationRef="#af8"><personName><givenNames>Pablo</givenNames><familyName>Martinez‐Martin</familyName><degrees>MD, PhD</degrees></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="NL" type="organization"><unparsedAffiliation>Department of Psychiatry, Maastricht University Medical Center, Maastricht, The Netherlands</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="FR" type="organization"><unparsedAffiliation>Neurology and Movement Disorders Unit, Lille University Hospital, Lille, France</unparsedAffiliation></affiliation><affiliation xml:id="af3" countryCode="US" type="organization"><unparsedAffiliation>Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA</unparsedAffiliation></affiliation><affiliation xml:id="af4" countryCode="US" type="organization"><unparsedAffiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA</unparsedAffiliation></affiliation><affiliation xml:id="af5" countryCode="US" type="organization"><unparsedAffiliation>Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA</unparsedAffiliation></affiliation><affiliation xml:id="af6" countryCode="US" type="organization"><unparsedAffiliation>Department of Psychiatry, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA</unparsedAffiliation></affiliation><affiliation xml:id="af7" countryCode="AU" type="organization"><unparsedAffiliation>School of Psychiatry, University of Western Australia and Fremantle Hospital, Fremantle, Western Australia, Australia</unparsedAffiliation></affiliation><affiliation xml:id="af8" countryCode="ES" type="organization"><unparsedAffiliation>Area of Applied Epidemiology and CIBERNED, National Centre for Epidemiology, Carlos III Institute of Health, Madrid, Spain</unparsedAffiliation></affiliation><affiliation xml:id="curr1" countryCode="US"><unparsedAffiliation>Laura Marsh Mental Health Care Line, Michael E. DeBakey Veterans Administration Medical Center and Menninger Department of Psychiatry, Baylor College of Medicine, Houston, Texas, USA</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">Parkinson's disease</keyword><keyword xml:id="kwd2">anxiety</keyword><keyword xml:id="kwd3">depression</keyword><keyword xml:id="kwd4">clinimetrics</keyword><keyword xml:id="kwd5">psychometrics</keyword><keyword xml:id="kwd6">rating scales</keyword><keyword xml:id="kwd7">validity</keyword><keyword xml:id="kwd8">reliability</keyword></keywordGroup><supportingInformation><p>
Additional Supporting Information may be found in the online version of this article.
</p><supportingInfoItem><mediaResource alt="supporting information" href="urn-x:wiley:08853185:media:mds23184:MDS_23184_sm_suppinfo"></mediaResource><caption>Supporting Information</caption></supportingInfoItem><supportingInfoItem><mediaResource alt="supporting information" href="urn-x:wiley:08853185:media:mds23184:MDS_23184_sm_suppinfoauthorrolesanddisclosures"></mediaResource><caption>Supporting Information Author Roles and Disclosures</caption></supportingInfoItem></supportingInformation><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><section xml:id="abs1-1"><title type="main">Background:</title><p>Anxiety is a prevalent and disabling condition in Parkinson's disease (PD). The lack of anxiety rating scales validated for this population hampers research into anxiety in PD. The aim of this study is to assess the clinimetric properties of the Hamilton anxiety rating scale (HARS), the Beck anxiety inventory (BAI), and the hospital anxiety and depression scale (HADS) in PD patients.</p></section><section xml:id="abs1-2"><title type="main">Design:</title><p>Three hundred forty‐two PD patients underwent a standardized assessment including a structured interview for diagnostic and statistical manual diagnoses of anxiety disorders and completion of the HARS, BAI, and HADS. Inter‐rater reliability of the HARS was assessed in 60 patients; test‐retest reliability of the BAI and HADS in 213 and 217 patients, respectively.</p></section><section xml:id="abs1-3"><title type="main">Results:</title><p>Thirty‐four percent of patients suffered from an anxiety disorder, whereas an additional 11.4% had clinically significant anxiety symptoms in the absence of a diagnosis of anxiety disorder. Acceptability, score distribution, and known groups validity over different levels of anxiety were adequate. Inter‐rater reliability for the HARS and test‐retest reliability for the BAI and HADS were good. The HARS, but not the BAI and HADS, had a satisfactory inter‐item correlation, convergent validity and factorial structure. For all scales, the positive predictive value was poor, and the negative predictive value was moderate.</p></section><section xml:id="abs1-4"><title type="main">Conclusions:</title><p>Given the adequate known groups validity of all three rating scales, each of these scales is likely to be useful in clinical practice or research for evaluation of symptom severity. Limitations in the construct validity of the anxiety scales in this study raise questions regarding suitability for their use in PD. © 2011 Movement Disorder Society</p></section></abstract></abstractGroup></contentMeta><noteGroup><note xml:id="fn1"><p><b>Relevant conflict of interest/financial disclosures:</b> Nothing to report. This study was sponsored by a grant from the Michael J Fox Foundation for Parkinson Research (MJFF; <url href="http://www.michaeljfox.org">www.michaeljfox.org</url>).</p><p>Full financial disclosures and author roles may be found in the online version of this article.</p></note></noteGroup></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Anxiety rating scales in Parkinson's disease: A validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Validation of Anxiety Rating Scales in PD</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Anxiety rating scales in Parkinson's disease: A validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale</title></titleInfo><name type="personal"><namePart type="given">Albert F.G.</namePart><namePart type="family">Leentjens</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Department of Psychiatry, Maastricht University Medical Center, Maastricht, The Netherlands</affiliation><affiliation>E-mail: a.leentjens@np.unimaas.nl</affiliation><affiliation>Correspondence address: Department of Psychiatry, Maastricht University Medical Center, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Kathy</namePart><namePart type="family">Dujardin</namePart><namePart type="termsOfAddress">PhD</namePart><affiliation>Neurology and Movement Disorders Unit, Lille University Hospital, Lille, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Laura</namePart><namePart type="family">Marsh</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA</affiliation><affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA</affiliation><affiliation>Current Address: Laura Marsh Mental Health Care Line, Michael E. DeBakey Veterans Administration Medical Center and Menninger Department of Psychiatry, Baylor College of Medicine, Houston, Texas, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Irene H.</namePart><namePart type="family">Richard</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA</affiliation><affiliation>Department of Psychiatry, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Sergio E.</namePart><namePart type="family">Starkstein</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>School of Psychiatry, University of Western Australia and Fremantle Hospital, Fremantle, Western Australia, Australia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Pablo</namePart><namePart type="family">Martinez‐Martin</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Area of Applied Epidemiology and CIBERNED, National Centre for Epidemiology, Carlos III Institute of Health, Madrid, Spain</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">2011-02-15</dateIssued><dateCaptured encoding="w3cdtf">2010-01-11</dateCaptured><dateValid encoding="w3cdtf">2010-03-23</dateValid><copyrightDate encoding="w3cdtf">2011</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><extent unit="figures">0</extent><extent unit="tables">7</extent><extent unit="references">42</extent><extent unit="words">8355</extent></physicalDescription><abstract>Anxiety is a prevalent and disabling condition in Parkinson's disease (PD). The lack of anxiety rating scales validated for this population hampers research into anxiety in PD. The aim of this study is to assess the clinimetric properties of the Hamilton anxiety rating scale (HARS), the Beck anxiety inventory (BAI), and the hospital anxiety and depression scale (HADS) in PD patients.</abstract><abstract>Three hundred forty‐two PD patients underwent a standardized assessment including a structured interview for diagnostic and statistical manual diagnoses of anxiety disorders and completion of the HARS, BAI, and HADS. Inter‐rater reliability of the HARS was assessed in 60 patients; test‐retest reliability of the BAI and HADS in 213 and 217 patients, respectively.</abstract><abstract>Thirty‐four percent of patients suffered from an anxiety disorder, whereas an additional 11.4% had clinically significant anxiety symptoms in the absence of a diagnosis of anxiety disorder. Acceptability, score distribution, and known groups validity over different levels of anxiety were adequate. Inter‐rater reliability for the HARS and test‐retest reliability for the BAI and HADS were good. The HARS, but not the BAI and HADS, had a satisfactory inter‐item correlation, convergent validity and factorial structure. For all scales, the positive predictive value was poor, and the negative predictive value was moderate.</abstract><abstract>Given the adequate known groups validity of all three rating scales, each of these scales is likely to be useful in clinical practice or research for evaluation of symptom severity. Limitations in the construct validity of the anxiety scales in this study raise questions regarding suitability for their use in PD. © 2011 Movement Disorder Society</abstract><note type="content">*Relevant conflict of interest/financial disclosures: Nothing to report. This study was sponsored by a grant from the Michael J Fox Foundation for Parkinson Research (MJFF; www.michaeljfox.org). Full financial disclosures and author roles may be found in the online version of this article.</note><subject lang="en"><genre>keywords</genre><topic>Parkinson's disease</topic><topic>anxiety</topic><topic>depression</topic><topic>clinimetrics</topic><topic>psychometrics</topic><topic>rating scales</topic><topic>validity</topic><topic>reliability</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><note type="content"> Additional Supporting Information may be found in the online version of this article.Supporting Info Item: Supporting Information - Supporting Information Author Roles and Disclosures - </note><subject><genre>article-category</genre><topic>Research Article</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><detail type="issue"><caption>no.</caption><number>3</number></detail><extent unit="pages"><start>407</start><end>415</end><total>9</total></extent></part></relatedItem><identifier type="istex">08277AF9837056E4B0F595949AA5A9C168BB6F93</identifier><identifier type="ark">ark:/67375/WNG-747J0S49-X</identifier><identifier type="DOI">10.1002/mds.23184</identifier><identifier type="ArticleID">MDS23184</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2011 Movement Disorder Society</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/document/08277AF9837056E4B0F595949AA5A9C168BB6F93/metadata/json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000163 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000163 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:08277AF9837056E4B0F595949AA5A9C168BB6F93
|texte= Anxiety rating scales in Parkinson's disease: A validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale
}}
| This area was generated with Dilib version V0.6.33. |  |